Featured
NEXT Summit in full swing in Sydney
Hundreds of pharma professionals have turned out for this year's much-anticipated NEXT Pharma Summit in Sydney for a sizzling hot conversation about the state of the local industry
Latest
Pharma boosts pipeline to 39 assets
A new strategic collaboration worth up to $453 million has expanded this company's pipeline to 39 biosimilars, with potential to increase up to 46
Regulatory & Reimbursement
Blockbuster earnings nosedive by 80%
When this top-earning PBS drug faced generic competition a year ago, a drop in price was expected but not the calamitous fall that actually occured
Regulatory & Reimbursement
14 drugs land on TGA's review desk
An update to the regulator's list of prescription medicines under review, shows six new drugs and eight new indications were accepted in June
Regulatory & Reimbursement
Fast response after PBAC Special Meeting
A snap meeting of the PBAC to replace a treatment being withdrawn from Australia has seen a result barely two weeks later
Industry & Companies
Who's the Most Productive pharma?
The inaugural Pipeline-to-Productivity Index is out - measuring R&D productivity, market access, and commercial return across the top 25 global pharmas
Industry & Companies
Sydney to host world RNA conference
In a significant milestone for Australia's RNA community, Sydney will host this Annual Meeting bringing thousands of leaders in the field Down Under
Regulatory & Reimbursement
Next stop Australia for 'oncology cornerstone'?
Potential best-in-class therapy and first anticancer treatment to be administered via an on-body injector could be heading Down Under
Regulatory & Reimbursement
Pharma expands offering in hotly contested space
The TGA has approved a new presentation of this company's RSV jab as it seeks to expand its reach in a competitive market by targeting a younger cohort
Jobs & Workplace
What happened to the Aussie pharma career ladder?
Redundancies, restructures and tighter headcounts have triggered a shift away from traditional linear career progression via promotions to more "sideways moves"
Featured
Big Pharma on Aussie hiring spree
In a breath of fresh air for the Australian industry - which has been hit hard by years of workforce downsizing across multiple companies - this Big Pharma is on a hiring spree
Jobs
Regulatory & Reimbursement
Johnson & Johnson pulls another drug
Company confirms it has decided to discontinue a long-standing cancer drug from the Australian market on the same day as its anaemia therapy due to an evolving treatment landscape
Leadership & People
AbbVie exec jumps to Medicines Australia
Senior leader named as Director of Policy and External Engagement just as the industry body heads into crucial Strategic Agreement negotiations with the Federal Government
Latest
'GLP-1 Brides' have a new problem to weigh
Brides-to-be have one more thing to worry about: they’re losing so much weight on GLP-1 drugs that their dresses no longer fit and some are even resorting to plastic surgery
Industry & Companies
Gene therapy could put sleep problem to bed
A new collaboration will work on the development of a treatment involving gene therapy for a condition that affects 10-20 per cent of middle-aged Australians
- Industry & Companies Lilly CEO calls out PBS pricing on Aussie TV
- Other News What's on Doctors' pharma wish list?
- Other News Oncologists emotionally connect to pharma brands
- Leadership & People Med Affairs boss stars on ABC TV show
- Regulation & Legal Shareholders accuse pharma of fraud
- Regulatory & Reimbursement Who's leading Australia's drug charge?
- Jobs & Workplace Successful 'Hunt' for company advisor
- Industry & Companies CSL ends next-gen vaccine collaboration
